Shanghai Fosun Pharmaceutical (Group) Co Ltd is a China-based company principally engaged in the research, development, manufacturing and sales of pharmaceutical products. The Company operates its businesses through five segments. The Pharmaceuticals segment is primarily engaged in the research, development, production and sales of pharmaceuticals. The Medical Devices and Diagnostics segment is primarily engaged in the research, development, production and sales of medical devices and diagnostic products. The Healthcare Services segment is primarily engaged in the provision of healthcare services and hospital management. The Pharmaceutical Distribution and Retail segment primarily engages in the distribution and retail of pharmaceuticals and medical devices. The Company also operates the Other segment. The Company mainly operates its businesses in the domestic market and overseas markets.
08-25
Interim Report
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHSENDED 30 JUNE 2026
PROPOSED SPIN-OFF LISTING OF FOSUN ADGENVAX (A SUBSIDIARY OF THE COMPANY) ON THE HONG KONG STOCK EXCHANGE; NOTICE OF EGM AND NOTICE OF H SHAREHOLDERS' CLASS MEETING